aibio
Listings ·
XBiotech tells Nasdaq of audit committee vacancy after director retires
W. Thorpe McKenzie retired from the board effective March 27, 2025. XBiotech will run one-member audit and compensation committees for now.
XBIT XBiotech Inc.
XBiotech (XBIT) news
Latest XBiotech news
We have not published a story on XBiotech yet. When there is news, it will appear here.
XBiotech annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Research and development | $47.4 million | $37.8 million |
| Net income (loss) | -$45.5 million | -$38.5 million |
| Cash from operations | -$39.9 million | -$31.0 million |
| Cash and equivalents | $125.6 million | $172.7 million |
Questions about XBiotech
What is the ticker symbol of XBiotech?
XBiotech Inc. trades under the ticker XBIT on NASDAQ.
Where is XBiotech listed?
XBiotech Inc. is listed on NASDAQ. Our directory also records these other listings: GETTEX:4XB; LSX:A14QF1.
What is the SEC CIK of XBiotech?
The SEC Central Index Key (CIK) for XBiotech Inc. is 1626878. Its filings are on SEC EDGAR.
How many shares does XBiotech have outstanding?
30,487,731 shares as of 2026-08-13, per the cover page of its 10-Q filed 2026-08-13.
Which country or territory is XBiotech listed under?
Our directory records XBiotech Inc. under United States.
What does XBiotech do?
Our directory classifies XBiotech Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline.
What is the ISIN of XBiotech?
The ISIN recorded for XBiotech Inc. is CA98400H1029.
Does aibio.space cover XBiotech?
aibio.space lists XBiotech Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Where is XBiotech incorporated?
SEC records list its state or country of incorporation as A1.
Is XBiotech profitable?
XBiotech Inc. reported a net loss of $45.5 million for the fiscal year ended Dec 31, 2025, and used $39.9 million of cash in operations, per its annual report to the SEC.
How much does XBiotech spend on research and development?
$47.4 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does XBiotech have?
$109.5 million in cash at Jun 30, 2026, per its 10-Q.
What is the latest XBiotech (XBIT) stock news?
Our latest story on XBiotech, dated Apr 7, 2025: "XBiotech tells Nasdaq of audit committee vacancy after director retires". W. Thorpe McKenzie retired from the board effective March 27, 2025. XBiotech will run one-member audit and compensation committees for now. Source.
Is XBiotech at risk of delisting?
Our latest listing story, dated Apr 7, 2025: "XBiotech tells Nasdaq of audit committee vacancy after director retires". W. Thorpe McKenzie retired from the board effective March 27, 2025. XBiotech will run one-member audit and compensation committees for now. Source.
What is XBiotech's market cap?
We do not publish live share prices. In its annual report, XBiotech Inc. put the market value of shares held by non-affiliates (public float) at $77.1 million as of Jun 30, 2025.
Investor discussion: XBiotech
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). Source
Stock chart
SEC filings and registration
- SEC name
- XBiotech Inc.
- CIK
- 1626878
- Industry (SIC)
- Pharmaceutical Preparations (2834)
- US tickers
- XBIT (Nasdaq)
- State or country of incorporation
- A1
- Fiscal year ends
- December 31
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Business address
- 5217 WINNEBAGO LANE, AUSTIN, TX, 78744
- Phone
- 512-386-2900
- Shares outstanding
- 30,487,731 as of 2026-08-13 (10-Q filed 2026-08-13)
Recent filings
Listing details
- Company
- XBiotech Inc.
- Ticker
- XBIT
- Listing
- NASDAQ
- Country or territory
- United States
- Business scope
- Biotechnology
- ISIN
- CA98400H1029
- Other listed symbols
- GETTEX:4XB; LSX:A14QF1
- Last quote in directory
- 2026-10-21
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction